07:00 - 08:00

lifecellSapphire sponsor LifeCell satellite symposium: 'The reconstruction of challenging colorectal defects'.

08:00 - 09:00

Free papers (main auditorium)

Chairs: Peter Paul L. O. Coene (The Netherlands), Pedro Correia da Silva (Portugal)

  • F13: Natural history of sigmoid diverticulitis: 5-year results of a prospective monocentric cohort study - Pascal Gervaz (Geneva University Hospital, Switzerland)
  • F14: The financial impact of patient re-admissions with diverticulitis, a 5 year experience of a UK hospital - Qamar Iqbal (Hillingdon Hospital NHS Foundation Trust, UK)
  • F15: Diverticular Disease emergency surgery in NHS Scotland 2000 to 2010 - Hugh Paterson (University of Edinburgh, UK and Edinburgh Colorectal Surgery Unit, Western General Hospital, UK)
  • F16: Ambulatory treatment versus Hospitalisation for uncomplicated diverticulitis - Thomas Golda (Bellvitge University Hospital, Spain)
  • F17: Transanal endoscopic surgery with 3-d TEM or high definition 2-d TEO. Prospective randomized controlled study - Xavier Serra-Aracil (Parc Tauli University Hospital, Spain)
  • F18: Laparoscopic selection bias must be considered if colorectal performance is to be measured using reoperation rates - Thomas Pinkney (University Hospital Birmingham, Department of Colorectal Surgery, UK)

Free papers (parallel auditorium)

Chairs: Anton Stift (Austria), Filippo La Torre (Italy)

  • F19: Peutz-Jeghers syndrome and truncating mutations in STK11 - Sreelakshmi Mallappa (The Polyposis Registry, St Mark's Hospital, UK)
  • F20: Outcome of management for rectovaginal fistula after rectal cancer surgery: a multicenter study - Kyu Joo Park (Seoul National University College of Medicine, Republic of Korea)
  • F21: Antibiotic prophylaxis administered without proper timing does not reduse surgical site infections after appendectomy - Ondrej Ryska (Department of Surgery, 2nd Faculty of Medicine, Charles University and Central Military Hospital, Czech Republic)
  • F22: Rectovaginal fistula: is early stoma confection the best option for cure ? Results of 194 procedures in 55 consecutive women - Hélène Corte (Beaujon Hospital, Colorectal Department and University Paris VII, France)
  • F23: A 23-hour discharge protocol for loop ileostomy closures - Oliver Peacock (School of Graduate Entry Medicine & Health, University of Nottingham, Royal Derby Hospital, UK)
  • F24: Short-term postoperative complications in patients treated with azathioprine for Crohn’s disease - Giulia Vitali (Sant'Orsola-Malpighi Hospital General Surgery Prof. Poggioli, Italy)

09:00 - 10:00

Symposium - Proctology

Chairs: Jirí Hoch (Czech Republic), Bruno Roche (Switzerland)

  • Management of anal intra-epithelial neoplasia - Per J. Nilsson (Sweden)
  • Perineal skin disorders - Eva Csatar (Hungary)
  • Novel approaches for treatment of anal fistula (LIFT, stem cells, new plugs?) - Dimitri Christoforidis (Switzerland)
10:00 - 10:10

ESCP Honorary Membership Award

Presented by incoming President Søren Laurberg


Best of the Six Best Papers Award

Awarded by BJS Secretary Ronan O’Connell

BJSPrize courtesy of British Journal of Surgery

10:10 - 10:40

Keynote lecture: SNS - time for critical appraisal

Speaker: Klaus Matzel (Germany)
Chair: Freddy Penninckx (Belgium)medtronic

Supported by a grant from by Medtronic

10:40 - 10:45

ESCP Fellowship Update

Lars Påhlman (Sweden), Klaus Matzel (Germany)

covidienSupported by Covidien

10:45 - 11:05


11:05 - 12:30

Consultants' corner

Convenors: Najib Haboubi (UK), Sarah O’Dwyer (UK), Mike Parker (UK)


Panel: Torbjörn Holm (Sweden), Mehmet Ayhan Kuzu (Turkey), Stefan Post (Germany), Béla Teleky (Austria), Yury Shelygin (Russia), Alan Thorson (USA)

Supported by a grant from Ethicon

12:30 - 13:00

Keynote lecture: Metastatic CRC - what about the primary?

Speaker: Irinel Popescu (Romania)
Chair: Peter Dawson (UK)

Introduced by BJS Secretary Ronan O’Connell

BJSSupported by a grant from British Journal of Surgery

13:00 - 14:30

Long lunch/exhibition/posters

View poster titles and presenters

13:15 - 14:30

ethiconSapphire Sponsor Ethicon satellite symposium: 'Recent evidence for the benefits of laparoscopy in colonic and rectal resections: review of the LAFA and COLOR II trials'.

13:00 - 15:00

Trainee surgeons' workshop and lunch

Chair: Ed Fitzgerald

  • Complications in colorectal surgery; what a Trainee needs to know
  • Trainee update on the management of colorectal cancer

14:30 - 15:30

Free papers (main auditorium)

Chairs: Alexander Herold (Germany), Sergii Podpriatov (Ukraine)

  • F25: Diagnostic accuracy of benign anal pathology: the effect of colorectal outpatient clinic attendance by medical students - Constantine Spanos (1st Department of Surgery, Aristotelian University, Greece)
  • F26: Stapled haemorrhoidopexy: a prospective audit from a 10 years database - Pierpaolo Sileri (Surgery, University of Rome Tor Vergata, Italy)
  • F27: Pre-operative mapping of fistula in ano: a new 3D MRI imaging technique - Nicholas Day (Wirral University Teaching Hospital NHS Foundation Trust, UK)
  • F28: Laparoscopic ventral mesh rectopexy: the treatment of choice for the resolution of solitary rectal ulcer syndrome - Thomas Roe (Frenchay Hospital, UK)
  • F29: Bowel dysfunction after low anterior resection with and without neoadjuvant therapy for rectal cancer - Sidse Bregendahl (Aarhus University Hospital, Denmark)
  • F30: Outcome of sacral nerve stimulation for faecal incontinence at five-year - Yasuko Maeda (Aalborg University Hospital, Denmark and St Mark’s Hospital, UK)

Free papers (parallel auditorium)

Chairs: Jean-Luc Faucheron (France), Josef Korcek (Slovakia)

  • F31: Could brain neuroplasticity be the mechanism involved in the control of continence by sacral nerve stimulation? Results of a prospective study in incontinent patients after switching the stimulator off - Ivana Giannini (University of Bari, Italy)
  • F32: Day-case laparoscopic ventral rectopexy: an achievable reality - Michael Powar (Cambridge University Hospitals, UK)
  • F33: Comparable outcomes of PTNS and SNS for Faecal Incontinence in two distinct patient cohorts - Alexander Hotouras (Academic Surgical Unit, Barts Heath NHS Trust, Queen Mary University of London, UK)
  • F34: Impact of rectopexy on sexual function - Hendrik A. Formijne Jonkers (Meander Medical Centre, The Netherlands)
  • F35: Does pelvic neuromonitoring contribute to quality assurance in rectal cancer surgery? - Daniel Kauff (University Medicine of the Johannes Gutenberg-University Mainz, Germany)
  • F36: Diversion colitis: endoscopy, morphology, microbiology, biochemistry - Alex Moscalev (National Scientific Center of Coloproctology, Russia)

15:30 - 16:30

Symposium: New technology

Chairs: Alexander Engel (Netherlands), Dainius Pavalkis (Lithuania)

  • Single-port transanal minimally invasive surgery for rectal tumours - Paolo Delrio (Italy)

  • Artificial anal sphincter - Paul-Antoine Lehur (France)

  • New laparoscopic energy devices - Dieter Hahnloser (Switzerland)

covidienSupported by a grant from Covidien

16:30 - 17:30

Oral posters (main auditorium)

Chairs: Ethem Gecin (Turkey), Evgeny Rybakov (Russia)

  • OP47: The efficacy of selective arterial embolisation in the treatment of lower gastrointestinal bleeding - Sanjay Adusumilli (University of Sydney, Australia and Westmead Hospital, Australia)
  • OP37: Identification of histopathologic indicators of oncologic bowel resection for submucosally invasive colorectal cancer - Shingo Tsujinaka (Jichi Medical University, Saitama Medical Center, Japan)
  • OP38: Management of malignant left colonic obstruction: is temporary colostomy followed by surgical resection the best option? - Jeremie Lefevre (Hopital Saint-Antoine, France)
  • OP39: Surgical resection of retrorectal tumors in adults: long term results in 47 patients - Jeremie Lefevre (Hopital Saint-Antoine, France)
  • OP40: Learning curve for robotic rectal cancer surgery - Rosa M Jimenez-Rodriguez (HU Virgen del Rocio, Spain)
  • OP41: Treatment of familial adenomatous polyposis based on results of genetic studies - Yuri Chubarov (National Scientific Center of Coloproctology, Russia)
  • OP42: Have early post-operative complications from laparoscopic rectal cancer surgery improved over the past 20 years? - Rosalyn Shearer (Aberdeen Royal Infirmary, UK)
  • OP43: Increased incidence of isolated lung metastases in lower rectal cancers below the peritoneal reflection: a prospectively collected database of 835 patients over 5 years in singapore - Aik-Yong Chok (Singapore General Hospital, Singapore)
  • OP44: Anastomotic leakage following curative resection for colonic cancer increases the rate of distant recurrence and long-term mortality - Peter-Martin Krarup (Bispebjerg Hospital, Denmark)
  • OP45: Sphincter function and neorectal sensation in Low anterior resection syndrome (LARS) - Katrine J. Emmertsen (Colorectal Surgical Department P, Aarhus University Hospital, Denmark)
  • OP46: Single-port colorectal surgery: a monocentric experience of 65 cases - Caroline Hatwell (Beaujon Hospital, Colorectal Department and University Paris VII, France)
  • OP48: Is laparoscopic surgery a risk factor for re-operation after elective colorectal surgery - Steph Michail (University Hospital Aintree, UK)

Oral posters (parallel auditorium)

Chairs: Jose M. Enriquez-Navascues (Spain), Marc Duinslaeger (Belgium)

  • OP49: Which patients who have rectoceles and obstructed defecation syndrome (ODS) actually need surgery - Liliana Bordeianou (Massachusetts General Hospital, USA)
  • OP50: Can proctographic criteria help predict the outcome of laparoscopic ventral rectopexy for internal rectal prolapse? - Frederic Ris (Department of Surgery, Geneva University hospitals, Switzerland and Department of Colorectal Surgery, Oxford University Hospitals, UK)
  • OP51: Elytrocele surgical correction by abdominal approach: 185 patients over a 10 years study - Diane Mege (Digestive Surgical Department, France)
  • OP53: Health-related quality of life after surgery for locally advanced primary rectal cancer and recurrent rectal cancer - Henriette Vind Thaysen (Aarhus University Hospital, Denmark)
  • OP54: Re-do (Revision) Surgery for Patients with Obstructed Defaecation Syndrome and Slow Colonic Transit - Mohamed Rabie (Queen Elizabeth the Queen Mother Hospital, UK and Ain Shams University, Egypt)
  • OP55: Anastomotic leakage after intersphincteric resection for low rectal cancer affects function and quality of life - Leon Maggiori (Beaujon Hospital - Paris 7 University, France)
  • OP56: The relationship between clinical symptoms and proctographic findings in patients with pelvic floor dysfunction - Gemma Faulkner (University Hospital of South Manchester, UK)
  • OP57: Laparoscopic ventral rectopexy using biological cross-linked mesh - Luana Franceschilli (Surgery, University of Rome Tor Vergata, Italy)
  • OP58: Close rectal dissection versus total mesorectal excision in ileal pouch-anal anastomosis: a randomized controlled trial - Sanne Bartels (Academic Medical Center, The Netherlands)
  • OP59: Restorative proctocolectomy (RPC) in patients with ulcerative colitis (UC): a cross sectional Danish population study on pouch function and quality of life - Søren Brandsborg (Aarhus University Hosptal, Denmark)
  • OP60: Has the role of a defunctioning stoma for large bowel Crohn’s disease changed in the biological era? - Marc Martí-Gallostra (Oxford Colorectal Center, UK and Hospital Universitari Vall Hebron, Spain)
  • OP35: Doppler-guided hemorrhoidal artery ligation with suture mucopexy vs. suture mucopexy alone for treatment of IIIº hemorrhoids. A prospective-randomized controlled trial - Felix Aigner (Department of Visceral, Transplant and Thoracic Surgery, Austria)


Closing ceremony

Søren Laurberg (President), Zoran Krivokpapic (Past President) Peter Dawson (Secretary), Donato Altomare (Programme Committee Chairman), Emmanuel Tiret (Past Programme Committee Chairman)

ESCP Affiliates